Lobe Sciences to Participate at the Advances in Mental Health Psychedelics and Non-Psychedelics Conference Cannabis Investing News
Johnson & Johnson Ebola Vaccine Regimen Demonstrated Robust and Durable Immune Response in Adults and Children in Data Published in The Lancet Infectious Diseases Medical Device Investing
Gilead to Present New Data at ESMO Congress 2021 Reinforcing the Practice-changing Potential of Trodelvy Biotech Investing
Avricore Health Engages Oak Hill Financial to Provide Investor Relations and Advisory Services Medical Device Investing
BELLUS Health Announces Positive Interim Analysis from the Phase 2b SOOTHE Trial of BLU-5937 in Refractory Chronic Cough Biotech Investing
According to New Multinational Survey, Healthcare Providers Believe Immunotherapy Has Potential to Positively Impact Earlier-Stage Cancer Treatment Landscape Across Tumor Types Biotech Investing
Opdivo Plus Yervoy Demonstrates Durable Overall Survival at Three Years Compared to Chemotherapy in First-Line Unresectable Malignant Pleural Mesothelioma in Phase 3 CheckMate -743 Trial Biotech Investing
Bristol Myers Squibb Shares Research Supporting Correlation Between New York Heart Association Functional Class and Mortality in Obstructive Hypertrophic Cardiomyopathy Biotech Investing
Cardiol Therapeutics Announces Acceleration of Expiry Date of Warrants Issued on June 4, 2020 Biotech Investing
